search
Company Information
USD
9.97
- (0.5%)
NASDAQ:BCRX, BIOCRYST PHARMACEUTICALS, INC.
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Address

4505 Emperor Boulevard
Suite 200

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. Alan G. Levin
Director
Mr. Jon P. Stonehouse
CEO/Director/President
Dr. Nancy J. Hutson, PhD
Chairman of the Board/Director
Mr. Vincent J. Milano
Director
Mr. Stephen J. Aselage
Director
Mr. George B. Abercrombie
Director
Dr. Steven Galson, M.D.
Director
Ms. Theresa M. Heggie
Director
Mr. Michael L. Jones
Other Corporate Officer
Mr. Anthony Doyle
CFO/Chief Accounting Officer/Treasurer
Ms. Machelle Sanders
Director
Dr. Amy McKee
Director
Ms. Alane Barnes
Chief Legal Officer/Secretary
Dr. Helen M. Thackray, M.D.
Other Executive Officer
Mr. Charles K. Gayer
Other Executive Officer

Ownership

Institution Holdings

BlackRock Inc
18,681,370 (9.062%)
Vanguard Group Inc
17,763,720 (8.617%)
Pharmakon Advisors L.P.
17,262,784 (8.374%)
venBio Select Advisor LLC
13,050,000 (6.330%)
Baker Bros. Advisors LP
12,710,818 (6.206%)
State Street Corporation
12,777,003 (6.198%)
Baker Bros Advisors LP
10,126,176 (4.912%)
SSGA Funds Management Inc
9,052,828 (4.391%)
BlackRock Fund Advisors
8,613,669 (4.178%)
Vanguard Investments Australia Ltd
6,839,664 (3.318%)

Individual Holdings

Mr. Jon P. Stonehouse
1,094,770 (0.532%)
Ms. Alane Barnes
293,539 (0.143%)
Mr. Charles K. Gayer
274,533 (0.134%)
Dr. Helen M. Thackray, M.D.
249,664 (0.122%)
Mr. Anthony Doyle
227,444 (0.111%)
Dr. Nancy J. Hutson, PhD
81,818 (0.043%)
Mr. Stephen J. Aselage
63,339 (0.034%)
Mr. Vincent J. Milano
51,997 (0.025%)
Ms. Theresa M. Heggie
51,860 (0.025%)
Mr. Alan G. Levin
37,090 (0.020%)

Funds Holdings

SPDR® S&P Biotech ETF
8,973,235 (4.353%)
Vanguard US Total Market Shares ETF
6,801,004 (3.299%)
Vanguard Total Stock Market Index Fund
6,801,004 (3.299%)
iShares Russell 2000 ETF
4,596,733 (2.230%)
Vanguard Institutional Extnd Mkt Idx Tr
3,131,071 (1.519%)
Vanguard Small Cap Index
2,614,789 (1.268%)
Fidelity Small Cap Index Fund
1,884,908 (0.914%)
iShares Biotechnology ETF
1,522,121 (0.738%)
CREF Stock Account
1,505,450 (0.730%)
Vanguard Small Cap Growth Index Fund
1,456,753 (0.707%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices